SHL Telemedicine Ltd, Tel Aviv (SHL), a company listed on the SIX Swiss Exchange, and Shanghai Jiuchuan Investment (Group) Co., Ltd, Shanghai (the Purchaser) have entered into a merger agreement, pursuant to which the Purchaser will, through one of its wholly owned subsidiary, acquire the entire share capital of SHL by way of a reverse triangular cross border merger. The transaction is subject to the approval by the shareholders' meetings. SHL is a leading provider and developer of advanced personal telemedicine solutions. VISCHER advises Shanghai Jiuchuan Investment (Group) Co., Ltd, on all capital markets, stock exchange and takeover law aspects in this transaction. The team is led by Matthias Staehelin (Partner) with (Ruben Masar and Desirée Dietlin (all Corporate).